WE BELIEVE TREATING THE ROOT CAUSE OF COMPLEX DISEASES – WITH PRECISION THERAPIES – IS WHERE WE’LL FIND THE NEXT MAJOR ADVANCE IN TREATMENT OUTCOMES.
<OUR mission_ is to redefine the treatment of infection-associated diseases by eliminating harmful bacteria early.>
THROUGH OUR MICROBIOME-SPARING, PATHOGEN-SPECIFIC DRUG CANDIDATES
We aim to selectively target pathogenic bacteria while preserving healthy microbial communities, supporting immune recovery and halting the progression of chronic and complex diseases.
If you examine the gut lining of patients with Crohn's disease, you will find that around 70 to 80 percent of them test positive for Adherent-invasive E. coli (AIEC) bacteria...
Our deeply experienced team has been
involved in 30+ IND filings, 6+ NDA approvals, founded 10+ companies and secured $350M+ in start-up financing.
The CMO will serve as Head of Clinical and Regulatory Affairs, responsible for designing and executing clinical development programs from first-in-human studies through pivotal trials. This includes oversight of regulatory submissions, such as INDs and NDAs, and leading communications with regulatory authorities. The role also requires forging and maintaining productive relationships with clinical trial sites, acting as the company’s Principal Investigator when necessary, and managing key vendor and CRO partnerships to ensure operational excellence.
Internally, the CMO will lead and mentor the clinical and regulatory teams, providing both strategic guidance and hands-on expertise to advance novel therapeutics through clinical proof-of-concept and beyond. As a member of the executive leadership team, the individual will collaborate across research, development, and corporate functions to align clinical strategy with the company’s broader objectives, bringing scientific rigor, medical insight, and regulatory acumen to every decision.
10+ years of leadership experience in the life sciences industry with a focus on small molecule therapeutics
Direct, hands-on experience with IND and NDA preparation and submission, as well as regulatory agency interactions (FDA, EMA, or equivalent)
Demonstrated success in designing, implementing, and managing multi-phase clinical trials
Experience serving as a Principal Investigator or senior medical lead in clinical development programs
Solid understanding of biostatistics, translational medicine, and clinical pharmacology
Proven ability to establish and maintain strong relationships with CROs, trial sites, vendors, and KOLs
Track record of building, leading, and mentoring high-performing clinical and regulatory teams
Excellent communication skills with the ability to represent the company to external partners, stakeholders, and regulatory bodies
Strategic thinker who can balance long-term vision with the operational demands of a growing biotech company
The CBO will serve as Head of Corporate and Business Development and Licensing, responsible for sourcing, structuring, and closing strategic collaborations, licensing agreements, and financing opportunities. The role requires a strong history of successful deal-making, demonstrated by a recent and robust deal sheet that includes closed partnerships with pharmaceutical companies across the U.S., Europe, and/or Japan. The candidate will collaborate closely with the CEO and Board of Directors to advance company pipeline programs, cultivate high-value partnerships, and secure innovative funding opportunities, including traditional financings and venture philanthropy models.
As a senior executive, the CBO will oversee the corporate and business development team, driving relationship-building across the biopharmaceutical ecosystem. In addition to managing partnerships, licensing, and financings, the individual will contribute to overall corporate strategy and help shape Flightpath Biosciences’ position as a trusted innovator in novel therapeutics. The role requires a dynamic, self-starting individual with exceptional relationship management skills, strong financial and strategic acumen, and an entrepreneurial spirit driven by the pursuit of impactful deal-making.
Advanced degree required: MBA or PhD
10+ years of relevant leadership experience in biotech or pharma corporate/business development
Demonstrated success in partnering small molecule therapeutics in infectious disease, cancer, and inflammatory diseases
Proven track record of closing and advancing complex partnerships, licensing agreements, and strategic collaborations, supported by a recent deal sheet with U.S., EU, and/or Japan partnerships
Experience in corporate strategy, financing transactions, and innovative funding models (including venture philanthropy)
Strong network across biopharmaceutical companies, investors, and industry stakeholders
Excellent negotiation and financial modeling skills, with a clear ability to drive deals to completion
Inspirational leadership with demonstrated management experience, fostering growth and execution within BD teams
Entrepreneurial mindset, highly motivated by transaction success and the ability to think creatively in driving partnerships
Strong communication skills with the ability to represent the company externally at the highest levels
If you are interested in a position with Flightpath Biosciences, please email your resume and cover letter to careers@flightpath.bio
